Pozzo, Carmelo
 Distribuzione geografica
Continente #
EU - Europa 1.436
NA - Nord America 1.144
AS - Asia 966
SA - Sud America 246
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3.823
Nazione #
US - Stati Uniti d'America 1.102
DE - Germania 684
SG - Singapore 436
CN - Cina 212
IT - Italia 203
BR - Brasile 197
SE - Svezia 188
IN - India 80
VN - Vietnam 76
FR - Francia 68
GB - Regno Unito 64
IE - Irlanda 45
FI - Finlandia 37
ID - Indonesia 37
UA - Ucraina 35
PL - Polonia 28
AR - Argentina 22
TR - Turchia 22
BD - Bangladesh 19
MX - Messico 19
RU - Federazione Russa 18
HK - Hong Kong 17
CA - Canada 16
EC - Ecuador 13
ZA - Sudafrica 11
ES - Italia 10
IQ - Iraq 10
IR - Iran 10
NL - Olanda 9
CZ - Repubblica Ceca 8
JP - Giappone 6
KR - Corea 6
AT - Austria 5
BE - Belgio 5
LT - Lituania 5
VE - Venezuela 5
CH - Svizzera 4
CI - Costa d'Avorio 4
JO - Giordania 4
PE - Perù 4
PK - Pakistan 4
SA - Arabia Saudita 4
TN - Tunisia 4
EG - Egitto 3
IL - Israele 3
MD - Moldavia 3
PT - Portogallo 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
CO - Colombia 2
DZ - Algeria 2
GG - Guernsey 2
GR - Grecia 2
HU - Ungheria 2
KE - Kenya 2
LK - Sri Lanka 2
RO - Romania 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
RS - Serbia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.823
Città #
Chandler 224
Singapore 218
Ashburn 140
Rome 64
Beijing 55
New York 51
Nürnberg 46
Dublin 39
Hyderabad 34
Los Angeles 34
Munich 33
Cattolica 30
Hefei 29
The Dalles 29
Jakarta 28
San Mateo 26
Marseille 25
São Paulo 25
Ho Chi Minh City 23
Frankfurt am Main 22
Chicago 20
Houston 20
Jacksonville 20
Wilmington 20
Princeton 19
Hanoi 17
Hong Kong 17
Nanjing 16
Boston 15
Milan 15
Santa Clara 15
Helsinki 13
Moscow 13
Kraków 12
Dallas 11
Warsaw 11
Johannesburg 10
Kent 10
Bari 9
Brooklyn 9
Chennai 9
Dearborn 9
Denver 9
Lappeenranta 9
Turku 9
Augusta 8
Boardman 8
Fairfield 8
Mexico City 8
Montreal 8
Brno 7
Istanbul 7
Izmir 7
London 7
Nuremberg 7
Bremen 6
Düsseldorf 6
Guangzhou 6
Leawood 6
Nanchang 6
Orem 6
Padova 6
Poplar 6
Redwood City 6
Stockholm 6
Woodbridge 6
Andover 5
Buenos Aires 5
Campinas 5
Costa Mesa 5
Gandhinagar 5
Guayaquil 5
Kish 5
Manchester 5
Phoenix 5
San Francisco 5
Seattle 5
Seoul 5
Tokyo 5
Abidjan 4
Amman 4
Atlanta 4
Brussels 4
Curitiba 4
Hải Dương 4
Mumbai 4
Pune 4
Querétaro 4
Quito 4
Tampa 4
Ankara 3
Arequipa 3
Baghdad 3
Bexley 3
Brasília 3
Buffalo 3
Cairo 3
Cambridge 3
Dhaka 3
Feira de Santana 3
Totale 1.792
Nome #
Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival 391
Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy 332
Impact of muscle mass loss on outcomes in advanced or metastatic gastric cancer patients receiving a second-line treatment 176
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 170
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 163
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 140
Enhanced recovery after surgery (ERAS) versus standard recovery for gastric cancer patients: The evidences and the issues: ERAS and Gastric Cancer 138
Clinical, pathological and prognostic features of rare braf mutations in metastatic colorectal cancer (Mcrc): A bi-institutional retrospective analysis (rebus study) 128
Body composition changes in gastric cancer patients during preoperative flot therapy: Preliminary results of an italian cohort study 123
Benefit of a multimodal approach combining chemotherapy and surgery in oligometastatic gastric cancer: experience from a tertiary referral center 120
Preoperative therapy and long-term survival in gastric cancer: One size does not fit all 119
A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer 115
Conversion Therapy With Encorafenib and Cetuximab for Chemo-Refractory BRAF V600E-Mutated Liver-Limited Colorectal Cancer Metastasis: The First Case Report 115
The Role of Surgery in the Management of Gastric Cancer: State of the Art 112
Skeletal Muscle Loss during Multikinase Inhibitors Therapy: Molecular Pathways, Clinical Implications, and Nutritional Challenges. 110
Muscle mass, assessed at diagnosis by L3-CT scan as a prognostic marker of clinical outcomes in patients with gastric cancer: A systematic review and meta-analysis. 107
Effects of nutritional interventions on nutritional status in patients with gastric cancer: A systematic review and meta-analysis of randomized controlled trials 103
The facts about food after cancer diagnosis: A systematic review of prospective cohort studies 97
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel 96
The Impact of a Multidisciplinary Tumor Board (MDTB) in the Management of Colorectal Cancer (CRC) 93
Neoadjuvant treatment: A window of opportunity for nutritional prehabilitation in patients with pancreatic ductal adenocarcinoma 93
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 90
Nutritional Support in Lung Cancer Patients: The State of the Art 89
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients 87
Prognostic value of skeletal muscle mass during tyrosine kinase inhibitor (TKI) therapy in cancer patients: a systematic review and meta-analysis 84
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 79
Real-world outcomes of Adjuvant De Gramont versus Xelox chemotherapy in reSected gasTric cancER: a propensity score-matched analysis (ASTER study) 70
Maintenance strategies after anti-EGFR-based induction in metastatic colorectal cancer: A systematic review and bayesian network meta-analysis 69
Predictive value of NLR, TILs (CD4+/CD8+) and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer 68
The impact of preoperative nutritional screening, ERAS protocol, and mini-invasive surgery in surgical oncology: A multi-institutional SEM analysis of patients with digestive cancer 65
A detailed analysis of the recurrence timing and pattern after curative surgery in patients undergoing neoadjuvant therapy or upfront surgery for gastric cancer 59
Treatment of locally advanced gastric cancer (LAGC): Back to lauren’s classification in pan– cancer analysis era? 58
Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy 27
Totale 3.886
Categoria #
all - tutte 14.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202191 0 0 0 0 0 4 14 6 26 8 28 5
2021/2022266 32 17 3 40 0 8 2 40 8 20 41 55
2022/2023574 74 74 39 93 17 78 42 43 48 9 13 44
2023/2024285 13 66 5 6 2 34 27 12 19 10 29 62
2024/2025721 16 14 63 25 66 24 34 24 79 95 165 116
2025/20261.143 244 73 138 271 344 73 0 0 0 0 0 0
Totale 3.886